AnaCardio
anacardio.com
Biotechnology
AnaCardio develops innovative drugs aimed at improving cardiac contractility to enhance clinical outcomes for heart failure patients. The company targets novel mechanisms to address unmet needs in cardiac therapeutics.
Founded
2017
Total Funding
Tens of millions
Total Rounds
1
First Raise
Sep 30, 2026
Latest Raise
Sep 30, 2026
Get notified when AnaCardio and companies like it raise
New funding rounds in your inbox every week 路 No noise, all Signal.
Organization Chart
Founders and leadership hierarchy for this company.
Contact details require Sales or Enterprise
Open Roles
Loading open roles...
All Funding Rounds
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 9/30/2026 | |||
Company Performance Metrics
Premium Feature
Upgrade to Premium to view Capital Momentum Score and performance metrics
AnaCardio 路 Never miss the next round
Who's raising next?
New funding rounds in your inbox every week 路 Free